Correlation Between Acrivon Therapeutics, and Zivo Bioscience
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Zivo Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Zivo Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Zivo Bioscience, you can compare the effects of market volatilities on Acrivon Therapeutics, and Zivo Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Zivo Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Zivo Bioscience.
Diversification Opportunities for Acrivon Therapeutics, and Zivo Bioscience
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Acrivon and Zivo is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Zivo Bioscience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zivo Bioscience and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Zivo Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zivo Bioscience has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Zivo Bioscience go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Zivo Bioscience
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 1.24 times more return on investment than Zivo Bioscience. However, Acrivon Therapeutics, is 1.24 times more volatile than Zivo Bioscience. It trades about 0.01 of its potential returns per unit of risk. Zivo Bioscience is currently generating about -0.03 per unit of risk. If you would invest 1,253 in Acrivon Therapeutics, Common on August 25, 2024 and sell it today you would lose (598.00) from holding Acrivon Therapeutics, Common or give up 47.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 31.99% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Zivo Bioscience
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Zivo Bioscience |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acrivon Therapeutics, and Zivo Bioscience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Zivo Bioscience
The main advantage of trading using opposite Acrivon Therapeutics, and Zivo Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Zivo Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zivo Bioscience will offset losses from the drop in Zivo Bioscience's long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. RenovoRx | Acrivon Therapeutics, vs. Tempest Therapeutics |
| Zivo Bioscience vs. RenovoRx | Zivo Bioscience vs. Pasithea Therapeutics Corp | Zivo Bioscience vs. Quoin Pharmaceuticals Ltd | Zivo Bioscience vs. Erasca Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |